riluzole has been researched along with Lung Diseases, Interstitial in 3 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Riluzole is the only approved oral drug for amyotrophic lateral sclerosis (ALS)." | 7.91 | Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study. ( Aoki, M; Inoue-Shibui, A; Izumi, R; Kato, M; Kawauchi, Y; Kobayashi, J; Kuroda, H; Suzuki, N; Takai, Y; Warita, H, 2019) |
| "A 74-year-old woman was clinically diagnosed with possible amyotrophic lateral sclerosis (ALS) and was administered 100 mg/day of riluzole." | 7.81 | [Riluzole-induced interstitial pneumonia in a case with amyotrophic lateral sclerosis]. ( Himeno, T; Kuriyama, M; Neshige, S; Shimoe, Y; Takamatsu, K; Takeshima, S, 2015) |
| "Riluzole (RZ)-induced interstitial lung disease (RZ-ILD) is a rare and potentially life-threatening adverse event in amyotrophic lateral sclerosis (ALS) patients, which is rarely reported." | 5.05 | Riluzole-induced interstitial lung disease is a rare and potentially life-threatening adverse event successfully treated with high-dose steroid therapy: Case reports and review of the literature. ( Abe, H; Aoshima, Y; Ariga, H; Mori-Yoshimura, M; Mukai, T; Okamoto, T; Saitoh, Y; Takahashi, Y, 2020) |
| "Riluzole is the only approved oral drug for amyotrophic lateral sclerosis (ALS)." | 3.91 | Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study. ( Aoki, M; Inoue-Shibui, A; Izumi, R; Kato, M; Kawauchi, Y; Kobayashi, J; Kuroda, H; Suzuki, N; Takai, Y; Warita, H, 2019) |
| "A 74-year-old woman was clinically diagnosed with possible amyotrophic lateral sclerosis (ALS) and was administered 100 mg/day of riluzole." | 3.81 | [Riluzole-induced interstitial pneumonia in a case with amyotrophic lateral sclerosis]. ( Himeno, T; Kuriyama, M; Neshige, S; Shimoe, Y; Takamatsu, K; Takeshima, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Saitoh, Y | 1 |
| Aoshima, Y | 1 |
| Mukai, T | 1 |
| Abe, H | 1 |
| Ariga, H | 1 |
| Mori-Yoshimura, M | 1 |
| Okamoto, T | 1 |
| Takahashi, Y | 1 |
| Inoue-Shibui, A | 1 |
| Kato, M | 1 |
| Suzuki, N | 1 |
| Kobayashi, J | 1 |
| Takai, Y | 1 |
| Izumi, R | 1 |
| Kawauchi, Y | 1 |
| Kuroda, H | 1 |
| Warita, H | 1 |
| Aoki, M | 1 |
| Takeshima, S | 1 |
| Neshige, S | 1 |
| Himeno, T | 1 |
| Takamatsu, K | 1 |
| Shimoe, Y | 1 |
| Kuriyama, M | 1 |
1 review available for riluzole and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Riluzole-induced interstitial lung disease is a rare and potentially life-threatening adverse event successfully treated with high-dose steroid therapy: Case reports and review of the literature.
Topics: Amyotrophic Lateral Sclerosis; Humans; Lung Diseases, Interstitial; Riluzole | 2020 |
2 other studies available for riluzole and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study.
Topics: Adult; Amyotrophic Lateral Sclerosis; Chemical and Drug Induced Liver Injury; Disease Progression; F | 2019 |
[Riluzole-induced interstitial pneumonia in a case with amyotrophic lateral sclerosis].
Topics: Aged; Amyotrophic Lateral Sclerosis; Female; Humans; Lung Diseases, Interstitial; Neuroprotective Ag | 2015 |